Across TCGA pan-cancer cohorts, SNORA36B RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNORA36B’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SNORA36B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA36B is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

LUSC, LUAD, and KIRC are the cancer types where SNORA36B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORA36B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	III,IV	+0.286	.049	1	view →
LUAD	All	All	+0.255	.022	1	view →
KIRC	All	IV	−0.102	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SNORA36B RNA expression & survival · all SNORA36B data types